The MTNR1B rs10830963 variant in interaction with pre-pregnancy BMI is a pharmacogenetic marker for the initiation of antenatal insulin therapy in gestational diabetes mellitus - Firneisz, G; Rosta, K; Al-Aissa, Z (Int J Mol Sci, 2018)
et al.